{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:57:37Z","timestamp":1787986657910,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The dissociation behaviours of aripiprazole and cariprazine at the human D<jats:sub>2<\/jats:sub>and D<jats:sub>3<\/jats:sub>receptor are evaluated. A potential correlation between kinetics and<jats:italic>in vivo<\/jats:italic>profiles, especially cariprazine\u2019s action on negative symptoms in schizophrenia, is investigated. The binding kinetics of four ligands were indirectly evaluated. After the receptor preparations were pre-incubated with the unlabelled ligands, the dissociation was initiated with an excess of [<jats:sup>3<\/jats:sup>H]spiperone. Slow dissociation kinetics characterizes aripiprazole and cariprazine at the D<jats:sub>2<\/jats:sub>receptor. At the D<jats:sub>3<\/jats:sub>receptor, aripiprazole exhibits a slow monophasic dissociation, while cariprazine displays a rapid biphasic behaviour. Functional \u00df-arrestin assays and molecular dynamics simulations at the D<jats:sub>3<\/jats:sub>receptor confirm a biphasic binding behaviour of cariprazine. This may influence its<jats:italic>in vivo<\/jats:italic>action, as the partial agonist could react rapidly to variations in the dopamine levels of schizophrenic patients and the ligand will not quantitatively dissociate from the receptor in one single step. With these findings novel agents may be developed that display rapid, biphasic dissociation from the D<jats:sub>3<\/jats:sub>R to further investigate this effect on<jats:italic>in vivo<\/jats:italic>profiles.<\/jats:p>","DOI":"10.1038\/s41598-018-30794-y","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T10:49:05Z","timestamp":1534330145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor"],"prefix":"10.1038","volume":"8","author":[{"given":"Annika","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra J.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy M.","family":"Keser\u0171","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-1710","authenticated-orcid":false,"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"30794_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fpsyt.2014.00047","volume":"5","author":"R Brisch","year":"2014","unstructured":"Brisch, R. et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front. Psychiatry 5, 47, https:\/\/doi.org\/10.3389\/fpsyt.2014.00047 (2014).","journal-title":"Front. Psychiatry"},{"key":"30794_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/ejn.13390","volume":"45","author":"P Sokoloff","year":"2017","unstructured":"Sokoloff, P. & Le Foll, B. The dopamine D3 receptor, a quarter century later. Eur. J. Neurosci. 45, 2\u201319 (2017).","journal-title":"Eur. J. Neurosci."},{"key":"30794_CR3","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1016\/j.bmcl.2012.03.104","volume":"22","author":"\u00c9 \u00c1gai-Csongor","year":"2012","unstructured":"\u00c1gai-Csongor, \u00c9. et al. Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3\/D2 receptors. Bioorg. Med. Chem. Lett. 22, 3437\u20133440 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"30794_CR4","doi-asserted-by":"publisher","unstructured":"Weso\u0142owska, A., Partyka, A., Jastrz\u0119bska-Wi\u0119sek, M. & Ko\u0142aczkowski, M. The preclinical discovery and development of cariprazine for the treatment of schizophrenia. Expert Opin. Drug Discov. in press, 1471057; https:\/\/doi.org\/10.1080\/17460441.2018.1471057 (2018).","DOI":"10.1080\/17460441.2018.1471057"},{"key":"30794_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(17)30060-0","volume":"389","author":"G N\u00e9meth","year":"2017","unstructured":"N\u00e9meth, G. et al. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial. Lancet 389, 1103\u20131113 (2017).","journal-title":"Lancet"},{"key":"30794_CR6","unstructured":"Copeland, R. A. Thermodynamics and Binding Kinetics in Drug Discovery [Keser\u00fc, G. M. & Swinney, D. C. (ed.)] Thermodynamics and Kinetics of Drug Binding, 157\u2013167 (Wiley Online Library, 2015)."},{"key":"30794_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10842","volume":"7","author":"C Klein Herenbrink","year":"2016","unstructured":"Klein Herenbrink, C. et al. The role of kinetic context in apparent biased agonism at GPCRs. Nat. Commun. 7, 10842, https:\/\/doi.org\/10.1038\/ncomms10842 (2016).","journal-title":"Nat. Commun."},{"key":"30794_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1017\/S1461145711000824","volume":"15","author":"L Carboni","year":"2012","unstructured":"Carboni, L. et al. Slow dissociation of partial agonists from the D(2) receptor is linked to reduced prolactin release. Int. J. Neuropsychopharmacol. 15, 645\u2013656 (2012).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"30794_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00210-012-0734-2","volume":"385","author":"G Vauquelin","year":"2012","unstructured":"Vauquelin, G., Bostoen, S., Vanderheyden, P. & Seeman, P. Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism. Naunyn Schmiedebergs Arch. Pharmacol. 385, 337\u2013372 (2012).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"30794_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schi\u00f6th, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: New agents, targets and indications. Nat. Rev. Drug Discov. 16, 829\u2013842 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"30794_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1566-2772(03)00021-5","volume":"3","author":"BL Roth","year":"2003","unstructured":"Roth, B. L., Sheffler, D. & Potkin, S. G. Atypical antipsychotic drug actions: unitary or multiple mechanisms for \u2018atypicality\u2019? Clin. Neurosci. Res. 3, 108\u2013117 (2003).","journal-title":"Clin. Neurosci. Res."},{"key":"30794_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1124\/jpet.111.190702","volume":"342","author":"X Langlois","year":"2012","unstructured":"Langlois, X. et al. Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia. J. Pharmacol. Exp. Ther. 342, 91\u2013105 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"30794_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature25758","volume":"555","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature 555, 269\u2013273 (2018).","journal-title":"Nature"},{"key":"30794_CR14","first-page":"161","volume":"25","author":"S Kapur","year":"2000","unstructured":"Kapur, S. & Seeman, P. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J. Psychiatry. Neurosci. 25, 161\u2013166 (2000).","journal-title":"J. Psychiatry. Neurosci."},{"key":"30794_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/10799898409041867","volume":"4","author":"JE Leysen","year":"1984","unstructured":"Leysen, J. E. & Gommeren, W. The dissociation rate of unlabelled dopamine antagonists and agonists from the dopamine-D2 receptor, application of an original filter method. J. Recept. Res. 4, 817\u2013845 (1984).","journal-title":"J. Recept. Res."},{"key":"30794_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0026-895X(25)14291-0","volume":"23","author":"DR Sibley","year":"1983","unstructured":"Sibley, D. R., Mahan, L. C. & Creese, I. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. Mol. Pharmacol. 23, 295\u2013302 (1983).","journal-title":"Mol. Pharmacol."},{"key":"30794_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1517\/14728222.10.4.515","volume":"10","author":"P Seeman","year":"2006","unstructured":"Seeman, P. Targeting the dopamine D2 receptor in schizophrenia. Expert. Opin. Ther. Targets 10, 515\u2013531 (2006).","journal-title":"Expert. Opin. Ther. Targets"},{"key":"30794_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/bph.12988","volume":"172","author":"M Wood","year":"2015","unstructured":"Wood, M., Dubois, V., Scheller, D. & Gillard, M. Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. Br. J. Pharmacol. 172, 1124\u20131135 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"30794_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1021\/acs.jcim.5b00457","volume":"56","author":"T Thomas","year":"2016","unstructured":"Thomas, T., Fang, Y., Yuriev, E. & Chalmers, D. K. Ligand binding pathways of clozapine and haloperidol in the dopamine D2 and D3 receptors. J. Chem. Inf. Model. 56, 308\u2013321 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"30794_CR20","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1021\/acs.jmedchem.6b01875","volume":"60","author":"A Bonifazi","year":"2017","unstructured":"Bonifazi, A. et al. Novel bivalent ligands based on the sumanirole pharmacophore reveal Dopamine D2 Receptor (D2R) biased agonism. J. Med. Chem. 60, 2890\u20132907 (2017).","journal-title":"J. Med. Chem."},{"key":"30794_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tips.2012.10.003","volume":"34","author":"JR Lane","year":"2013","unstructured":"Lane, J. R., Sexton, P. M. & Christopoulos, A. Bridging the gap: Bitopic ligands of G-protein-coupled receptors. Trends Pharmacol. Sci. 34, 59\u201366 (2013).","journal-title":"Trends Pharmacol. Sci."},{"key":"30794_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.tips.2017.05.005","volume":"38","author":"A Strasser","year":"2017","unstructured":"Strasser, A., Wittmann, H.-J. & Seifert, R. Binding kinetics and pathways of ligands to GPCRs. Trends Pharmacol. Sci. 38, 717\u2013732 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"30794_CR23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1124\/mol.113.088054","volume":"84","author":"JR Lane","year":"2013","unstructured":"Lane, J. R. et al. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors. Mol. Pharmacol. 84, 794\u2013807 (2013).","journal-title":"Mol. Pharmacol."},{"key":"30794_CR24","doi-asserted-by":"publisher","first-page":"18488","DOI":"10.1073\/pnas.1104807108","volume":"108","author":"JA Allen","year":"2011","unstructured":"Allen, J. A. et al. Discovery of \u03b2-arrestin\u2013biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc. Natl. Acad. Sci. USA 108, 18488\u201318493 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"30794_CR25","doi-asserted-by":"publisher","first-page":"13656","DOI":"10.1073\/pnas.0803522105","volume":"105","author":"B Masri","year":"2008","unstructured":"Masri, B. et al. Antagonism of dopamine D2 receptor\/\u03b2-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc. Natl. Acad. Sci. USA 105, 13656\u201313661 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"30794_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drudis.2017.07.016","volume":"23","author":"RHA Folmer","year":"2018","unstructured":"Folmer, R. H. A. Drug target residence time: a misleading concept. Drug Discov. Today 23, 12\u201316 (2018).","journal-title":"Drug Discov. Today"},{"key":"30794_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0922-4106(92)90107-7","volume":"225","author":"P Sokoloff","year":"1992","unstructured":"Sokoloff, P. et al. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur. J. Pharmacol. 225, 331\u2013337 (1992).","journal-title":"Eur. J. Pharmacol."},{"key":"30794_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fchem.2017.00064","volume":"5","author":"M Sch\u00fcbler","year":"2017","unstructured":"Sch\u00fcbler, M., Sadek, B., Kottke, T., Weizel, L. & Stark, H. Synthesis, molecular properties estimations, and dual dopamine D2 and D3 receptor activities of benzothiazole-based ligands. Front. Chem. 5, 64, https:\/\/doi.org\/10.3389\/fchem.2017.00064 (2017).","journal-title":"Front. Chem."},{"key":"30794_CR29","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"C Yung-Chi","year":"1973","unstructured":"Yung-Chi, C. & Prusoff, W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099\u20133108 (1973).","journal-title":"Biochem. Pharmacol."},{"key":"30794_CR30","doi-asserted-by":"crossref","unstructured":"Bosma, R., Mocking, T. A.M., Leurs, R. & Vischer, H. F. Ligand-Binding Kinetics on Histamine Receptors [Tiligada, E. & Ennis, M. (ed.)] Histamine Receptos as Drug Targets, 115\u2013155 (Springer Science\u2009+\u2009Business Media LLC, New York, USA).","DOI":"10.1007\/978-1-4939-6843-5_5"},{"key":"30794_CR31","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1111\/bph.12683","volume":"171","author":"DC Swinney","year":"2014","unstructured":"Swinney, D. C. et al. A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands. Br. J. Pharmacol. 171, 3364\u20133375 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"30794_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.1197410","volume":"330","author":"EYT Chien","year":"2010","unstructured":"Chien, E. Y. T. et al. Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist. Science 330, 1091\u20131095 (2010).","journal-title":"Science"},{"key":"30794_CR33","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theor. Comp. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theor. Comp."},{"key":"30794_CR34","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1021\/j100142a004","volume":"97","author":"CI Bayly","year":"1993","unstructured":"Bayly, C. I., Cieplak, P., Cornell, W. & Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J. Phys. Chem. 97, 10269\u201310280 (1993).","journal-title":"J. Phys. Chem."},{"key":"30794_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/acs.jcim.7b00680","volume":"58","author":"S Decherchi","year":"2018","unstructured":"Decherchi, S., Bottegoni, G., Spitaleri, A., Rocchia, W. & Cavalli, A. BiKi Life Sciences: a new suite for molecular dynamics and related methods in drug discovery. J. Chem. Inf. Model. 58, 219\u2013224 (2018).","journal-title":"J. Chem. Inf. Model."},{"key":"30794_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845\u2013854 (2013).","journal-title":"Bioinformatics"},{"key":"30794_CR37","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1021\/acs.jctc.7b01088","volume":"14","author":"A Spitaleri","year":"2018","unstructured":"Spitaleri, A., Decherchi, S., Cavalli, A. & Rocchia, W. Fast dynamic docking guided by adaptive electrostatic bias: the MD-Binding approach. J. Chem. Theor. Comp. 14, 1727\u20131736 (2018).","journal-title":"J. Chem. Theor. Comp."},{"key":"30794_CR38","doi-asserted-by":"publisher","first-page":"e59744","DOI":"10.1371\/journal.pone.0059744","volume":"8","author":"S Decherchi","year":"2013","unstructured":"Decherchi, S. & Rocchia, W. A general and robust ray-casting-based algorithm for triangulating surfaces at the nanoscale. PloS one 8, e59744 (2013).","journal-title":"PloS one"},{"key":"30794_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1021\/ci600342e","volume":"47","author":"G Marcou","year":"2007","unstructured":"Marcou, G. & Rognan, D. Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J. Chem. Inf. Model. 47, 195\u2013207 (2007).","journal-title":"J. Chem. Inf. Model."},{"key":"30794_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep11539","volume":"5","author":"L Mollica","year":"2015","unstructured":"Mollica, L. et al. Kinetics of protein-ligand unbinding via smoothed potential molecular dynamics simulations. Sci. Rep. 5, 11539, https:\/\/doi.org\/10.1038\/srep11539 (2015).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30794-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T10:24:17Z","timestamp":1751797457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30794-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30794"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30794-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"17 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.M.K. contributed to the discovery of cariprazine. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12509"}}